FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Share Price

Certificat

DE000MG394E8

Real-time Bid/Ask 15:05:36 19/06/2024 BST
3.68 EUR / 4.15 EUR +6.97% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month+21.59%
1 month+1.10%
Date Price Change
19/06/24 3.68 +0.55%
18/06/24 3.66 +3.98%
17/06/24 3.52 +7.98%
14/06/24 3.26 +16.01%
13/06/24 2.81 +3.69%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 11:37 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG394E
ISINDE000MG394E8
Date issued 29/04/2024
Strike 100.8 $
Maturity Unlimited
Parity 2.28 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.15
Lowest since issue 2.52
Spread 0.45
Spread %10.90%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
91.66 USD
Average target price
108.2 USD
Spread / Average Target
+18.00%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW